Bayer HealthCare and Onyx Pharmaceuticals, Inc. announced cancer medicines Regorafenib for the treatment of adult patients with metastatic colorectal cancer (mCRC). This medication is a kinase inhibitor, prescribed for metastatic colorectal cancer (CRC) in patients who have been previously treated with other chemotherapy. It works by helping to stop cancer cells from growing.
Available Brand Names of Regorafenib at Oddwayinternational.com are:
- Resihance Regorafenib 40mg Tablets
- Nublexa Regorafenib 40mg Tablets
Find out more information about Regorafenib Tablets uses, details, side effect, precaution and many other after visiting our website. @https://goo.gl/EMwekJ
